Michael Griffin
Stock Analyst at Citigroup
(2.92)
# 1,684
Out of 5,090 analysts
15
Total ratings
100%
Success rate
26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JLL Jones Lang LaSalle | Maintains: Neutral | $275 → $240 | $327.64 | -26.75% | 5 | May 28, 2025 | |
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $160.86 | -0.53% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $50.11 | -72.06% | 1 | Mar 4, 2024 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $17.40 | -2.30% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $35 → $32 | $13.48 | +133.68% | 2 | May 19, 2023 |
Jones Lang LaSalle
May 28, 2025
Maintains: Neutral
Price Target: $275 → $240
Current: $327.64
Upside: -26.75%
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $160.86
Upside: -0.53%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $50.11
Upside: -72.06%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $17.40
Upside: -2.30%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $35 → $32
Current: $13.48
Upside: +133.68%